［1］Drr H, Abend M, Blakely WF, et al. Using Clinical Signs and Symptoms for Medical Management of Radiation Casualties - 2015 NATO Exercise ［J］. Radiat Res, 2017, 187(3): 273-286.
［2］Nagata S. The Cytokine Handbook ［M］. New York: Academic Press, 1994：371.
［3］Drouet M, Delaunay C, Grenier N, et al. Cytokines in combination to treat radiation-induces myelosuppression: evaluation of SCF+ glycosylated EPO+ pegylated G-CSF as an emergency treatment in highly irradiated monkeys ［J］. Haematologica, 2008, 93(3): 465-466.
［4］Liu JF, Du ZD, Chen Z, et al. Granulocyte colony-stimulating factor attenuates monocrotaline-induced pulmonary hypertension by upregulating endothelial progenitor cells via the nitric oxide system ［J］. Exp Ther Med, 2013, 6(6): 1402-1408.
［5］Farese AM, Cohen MV, Katz BP, et al. Filgrastim improves survival in lethally irradiated nonhuman primates ［J］. Radiat Res, 2013, 179(1): 89-100.
［6］Becker P, Schwebig A, Brauninger S, et al. Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performance ［J］. Transfusion, 2016, 56(12): 3055-3064.
［7］Gluzman-Poltorak Z, Vainstein V. Recombinant interleukin-12, but not granulocyte-colony stimulating factor, improves survival in lethally irradiated nonhuman primates in the absence of supportive care: evidence for the development of a frontline radiation medical countermeasure ［J］. Am J Hematol, 2014, 89: 868-873.
［8］Culy CR, Spencer CM. Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemothera-py or radiotherapy and its potential therapeutic application in mylodysplastic syndrome ［J］. Drugs, 2001, 61(5): 641-684.
［9］Rasey JS, Spence AM, Badger CC, et al. Specific protection of different normal tissues ［J］. Pharmacol Ther, 1988, 39(1-3): 33-43.
［10］Miller RC, Murley JS, Grdina DJ. Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs ［J］. Radiat Res, 2014, 181(5): 464-470.
［11］Seed TM, Inal CE, Singh VK. Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis ［J］. Int J Radiat Biol, 2014, 90(7): 594-604.
［12］Seed TM. Radiation protectants: current status and furture prospects ［J］. Health Phys, 2005, 89(5): 531-545.
［13］Singh VK, Hauer-Jensen M. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status ［J］. Int J Mol Sci, 2016, 17(5): E663.
［14］de Freitas RB, Boligon AA, Rovani BT, et al. Effect of black grape juice against heart damage from acute gamma TBI in rats ［J］. Molecules, 2013, 18(10): 12 154-12 167.
［15］Ghosh SP, Kulkarni S, Hieber K, et al. Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector ［J］. Int J Radiat Biol, 2009, 85(7): 598-606.
［16］Singh VK, Beattie LA, Seed TM. Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures ［J］. J Radiat Res, 2013, 54(6): 973-988.
［17］Kulkarni S, Chosh SP, Satyamitra M, et al. γ-Tocotrienol protects hematopoietic stem and progenitor cells in mice after total-body irradiation ［J］. Radiat Res, 2010,173(6): 738-747.
［18］Suman S, Datta K, Chakraborty K, et al. Gamma tocotrienol, a potent radioprotector, preferentially upregulates expression of anti-apoptotic genes to promote intestinal cell survival ［J］. Food Chem Toxicol, 2013, 60:488-496.
［19］Bai M, Ma X, Wang X, et al. The Accomlipation of NF-κB Lead to Radioresistance ［J］. Curr Protein Pept Sci, 2015, 16(4): 279-294.
［20］Wang Y, Park NY, Jang Y, et al. Vitamine Eγ-Tocotrienol inhibits cytokine-stimulated NF-κB activation by induction of anti-inflammatory A20 via stress adaptive response due to modulation of sphingolipids ［J］. J Immunol, 2015, 195: 126-133.
［21］Ray S, Kulkarni SS, Chakraborty K, et al. Mobilization of progenitor cells into peripheral blood by γ-tocotrienol: a promissing radiation countermeasure ［J］. Int Immunopharmacol, 2013, 15(3): 557-564.
［22］Singh VK, Fatanmi, Wise, et al. The potentiation of the radioprotective efficacy of two medical countermeasures, γ-Tocotrienol and amifostine, by a combination prophylactic modality ［J］. Radiat Prot Dosimetry, 2016, 172(1-3):302-310.
［23］Stickney DR, Dowding C, Authier S, et al. 5‐androstenediol improves survival in clinically unsupported rhesus monkeys with radiation-induced myelosuppression ［J］. Int Immunopharmacol, 2007, 7(4): 500-505.
［24］Kim JS, Jang WS, Lee S, et al. A study of the effect of sequential injection of 5-androstenediol on irradiation-induced myelosuppression in mice ［J］. Arch Pharm Res, 2015, 38(6): 1213-1222.
［25］Grace MB, Singh VK, Rhee JG, et al.5-AED enhances survival〖JP〗 of irradiated mice in a G-CSF-dependent manner, stimulates innate immune cell function, reduces radiation-induced DNA damage and induces genes that modulate cell cycle progression and apoptosis ［J］. J Radiat Res, 2012, 53(6): 840-853.
［26］Whitnall MH, Villa V, Seed TM, et al. Molecular specificity of 5-androstenediol as a systemic radioprotectant in mice ［J］. Immunopharmacol Immunotoxicol, 2005, 27（1）:15-32.
